CompletedNot Applicable

Psychological Treatment for Persistent Fatigue

Sweden18 participantsStarted 2024-04-11

Plain-language summary

This is a non-randomized pilot study to investigate the feasibility and acceptability of a transdiagnostic psychological intervention for primary care patients in Region Stockholm, Sweden, who suffer from persistent and disabling fatigue.

Who can participate

Age range18 Years – 67 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age 18-67
✓. severe, functionally disabling fatigue as a central symptom for at least 3 months
✓. The fatigue is not a direct effect of an active disease process motivating another treatment (e.g., hypo-/hyperthyroidism, anemia, cancer, dementia) or the effect of medication
✓. regular access to a computer and to the Internet
✓. ability to read and write in Swedish.

Exclusion criteria

✕. substance abuse disorder in the past 6 months
✕. Current or past psychosis or bipolar disorder
✕. Primary psychiatric disorder of such severity that it merits evidence-based treatment (e.g., obsessive compulsive disorder, moderate to severe depression, post-traumatic stress disorder)
✕. elevated risk for suicide
✕. anorexia nervosa
✕. BMI\>40
✕. Initiated or changed psychopharmacological medication (e.g., for depression or anxiety disorders) in the past month
✕. ongoing chemotherapy

What they're measuring

Treatment adherence and completion

Timeframe: Post-treatment (6 months)

Treatment credibility

Timeframe: Three weeks after treatment start

Patient satisfaction

Timeframe: Post-treatment (6 months)

Working alliance

Timeframe: Week 3 and 15 of treatment

Negative effects of treatment

Timeframe: Post-treatment (6 months)

Open-ended questions regarding treatment content and presentation

Timeframe: Post-treatment (6 months)

Trial details

NCT IDNCT06341751

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-15

View on ClinicalTrials.gov More Fatigue trials

Who can participate

Age range18 Years – 67 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age 18-67
✓. severe, functionally disabling fatigue as a central symptom for at least 3 months
✓. The fatigue is not a direct effect of an active disease process motivating another treatment (e.g., hypo-/hyperthyroidism, anemia, cancer, dementia) or the effect of medication
✓. regular access to a computer and to the Internet
✓. ability to read and write in Swedish.

Exclusion criteria

✕. substance abuse disorder in the past 6 months
✕. Current or past psychosis or bipolar disorder
✕. Primary psychiatric disorder of such severity that it merits evidence-based treatment (e.g., obsessive compulsive disorder, moderate to severe depression, post-traumatic stress disorder)
✕. elevated risk for suicide
✕. anorexia nervosa
✕. BMI\>40
✕. Initiated or changed psychopharmacological medication (e.g., for depression or anxiety disorders) in the past month
✕. ongoing chemotherapy

What they're measuring

Treatment adherence and completion

Timeframe: Post-treatment (6 months)

Treatment credibility

Timeframe: Three weeks after treatment start

Patient satisfaction

Timeframe: Post-treatment (6 months)

Working alliance

Timeframe: Week 3 and 15 of treatment

Negative effects of treatment

Timeframe: Post-treatment (6 months)

Open-ended questions regarding treatment content and presentation

Timeframe: Post-treatment (6 months)